$0 is the total value of Granite Point Capital Management, L.P.'s 1 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 200.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | NONE TO REPORTnone | $0 | – | 0 | +100.0% | 0.00% | – | |
| YNDX | Exit | YANDEX N V | $0 | – | -49,000 | -100.0% | -100.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-07
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| META PLATFORMS INC | 37 | Q1 2023 | 3.9% |
| AMAZON COM INC | 33 | Q1 2023 | 5.9% |
| ALIBABA GROUP HLDG LTD | 30 | Q1 2023 | 1.7% |
| TAL EDUCATION GROUP | 28 | Q4 2022 | 0.9% |
| ISHARES TR | 27 | Q2 2022 | 55.1% |
| ALPHABET INC | 25 | Q1 2023 | 2.7% |
| APPLE INC | 25 | Q1 2023 | 2.3% |
| AXOGEN INC | 24 | Q1 2022 | 2.5% |
| RINGCENTRAL INC | 24 | Q4 2022 | 0.7% |
| ADVANCED MICRO DEVICES INC | 22 | Q1 2023 | 8.5% |
View Granite Point Capital Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neuronetics, Inc.Sold out | January 26, 2022 | 0 | 0.0% |
| Sientra, Inc. | February 12, 2021 | 2,396,000 | 4.7% |
| MARINUS PHARMACEUTICALS INC | January 27, 2020 | 1,368,811 | 1.6% |
View Granite Point Capital Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-07 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-04 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-11 |
| 13F-HR | 2022-02-11 |
| SC 13G/A | 2022-01-26 |
| 13F-HR | 2021-11-10 |
View Granite Point Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.